ES2537572T3 - Análogos de desoxinojirimicina y D-arabinitol y métodos de uso - Google Patents

Análogos de desoxinojirimicina y D-arabinitol y métodos de uso Download PDF

Info

Publication number
ES2537572T3
ES2537572T3 ES07797651.2T ES07797651T ES2537572T3 ES 2537572 T3 ES2537572 T3 ES 2537572T3 ES 07797651 T ES07797651 T ES 07797651T ES 2537572 T3 ES2537572 T3 ES 2537572T3
Authority
ES
Spain
Prior art keywords
groups
substituted
unsubstituted
compound
dnj
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07797651.2T
Other languages
English (en)
Spanish (es)
Inventor
Terry D. Butters
Raymond A. Dwek
George W.J. Fleet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United Therapeutics Corp
Original Assignee
United Therapeutics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United Therapeutics Corp filed Critical United Therapeutics Corp
Application granted granted Critical
Publication of ES2537572T3 publication Critical patent/ES2537572T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES07797651.2T 2006-05-24 2007-05-22 Análogos de desoxinojirimicina y D-arabinitol y métodos de uso Active ES2537572T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80277606P 2006-05-24 2006-05-24
US802776P 2006-05-24
PCT/US2007/069448 WO2007140184A2 (en) 2006-05-24 2007-05-22 Deoxynojirimycin and d-arabinitol analogs and methods of using

Publications (1)

Publication Number Publication Date
ES2537572T3 true ES2537572T3 (es) 2015-06-09

Family

ID=38779322

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07797651.2T Active ES2537572T3 (es) 2006-05-24 2007-05-22 Análogos de desoxinojirimicina y D-arabinitol y métodos de uso

Country Status (8)

Country Link
US (1) US8975280B2 (US20040106767A1-20040603-C00005.png)
EP (1) EP2023927B1 (US20040106767A1-20040603-C00005.png)
JP (2) JP5241709B2 (US20040106767A1-20040603-C00005.png)
CN (2) CN104876855A (US20040106767A1-20040603-C00005.png)
CA (1) CA2652958C (US20040106767A1-20040603-C00005.png)
ES (1) ES2537572T3 (US20040106767A1-20040603-C00005.png)
HK (1) HK1214261A1 (US20040106767A1-20040603-C00005.png)
WO (1) WO2007140184A2 (US20040106767A1-20040603-C00005.png)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008088581A2 (en) * 2006-08-02 2008-07-24 United Therapeutics Corporation Liposome treatment of viral infections
WO2009118658A2 (en) * 2008-03-26 2009-10-01 University Of Oxford Endoplasmic reticulum targeting liposomes
ES2579628T3 (es) 2009-02-23 2016-08-12 Emergent Virology Llc Iminoazúcares y métodos de tratamiento de enfermedades virales
JP5951996B2 (ja) * 2009-02-24 2016-07-13 ユナイテッド セラピューティクス コーポレーション イミノ糖及びアレナウイルス感染症を治療する方法
JP2012521981A (ja) * 2009-03-27 2012-09-20 ザ チャンセラー，マスターズ アンド スカラーズ オブ ザ ユニバーシティ オブ オックスフォード コレステロールレベル低下リポソーム
US20100248365A1 (en) * 2009-03-27 2010-09-30 Zacharon Pharmaceuticals, Inc. Ganglioside biosynthesis modulators
JP5634510B2 (ja) * 2009-06-12 2014-12-03 ユナイテッド セラピューティクス コーポレイション イミノ糖ならびにブニヤウイルスおよびトガウイルス疾患を治療する方法
CN102625796B (zh) * 2009-09-04 2015-03-11 联合治疗公司 治疗正粘病毒感染的方法
ES2527623T3 (es) * 2009-09-04 2015-01-27 United Therapeutics Corporation Iminoazúcares para su uso en el tratamiento de enfermedades por filovirus
WO2011028781A1 (en) * 2009-09-04 2011-03-10 United Therapeutics Corporation Methods of treating poxviral infections
JP2015518896A (ja) 2012-06-06 2015-07-06 ユニザー ヴィロロジー，エルエルシー 新規イミノ糖およびそれらの用途
CA2906675A1 (en) * 2013-03-15 2014-09-18 Unither Virology, Llc Antibacterial compounds
CN106102464A (zh) * 2013-05-02 2016-11-09 牛津大学之校长及学者 采用亚氨基糖的糖脂抑制
KR20160055916A (ko) 2013-09-16 2016-05-18 이머전트 바이롤로지 엘엘씨 데옥시노지리마이신 유도체 및 그의 이용 방법
SG10201903630UA (en) * 2014-11-05 2019-05-30 Emergent Virology Llc Iminosugars useful for the treatment of viral diseases
EP3318277A1 (en) 2016-11-04 2018-05-09 Institut du Cerveau et de la Moelle Epiniere-ICM Inhibitors of glucosylceramide synthase for the treatment of motor neuron diseases

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154918C (no) 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
JPS54106477A (en) 1978-02-03 1979-08-21 Nippon Shinyaku Co Ltd Moranoline derivative
JPS5943948B2 (ja) * 1978-07-06 1984-10-25 日本新薬株式会社 置換モラノリン誘導体
JPS5943949B2 (ja) 1978-09-29 1984-10-25 日本新薬株式会社 モラノリンのｎ−置換誘導体
JPS5943947B2 (ja) * 1978-05-03 1984-10-25 日本新薬株式会社 Ｎ−置換モラノリン誘導体
GB2020278B (en) 1978-05-03 1983-02-23 Nippon Shinyaku Co Ltd Moranoline dervitives
DE3007078A1 (de) 1980-02-26 1981-09-10 Bayer Ag, 5090 Leverkusen Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung
DE3024901A1 (de) 1980-07-01 1982-01-28 Bayer Ag, 5090 Leverkusen Herbizide mittel auf basis von piperidin-derivaten
DE3620645A1 (de) 1985-12-20 1987-07-02 Bayer Ag 3-amino-4,5-dihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung
JPS62155291A (ja) 1985-12-20 1987-07-10 バイエル・アクチエンゲゼルシヤフト ３−アミノ−４，５−ジヒドロキシピペリジン類、それらの製造方法及びそれらの使用
DE3737523A1 (de) 1987-11-05 1989-05-18 Bayer Ag Verwendung von substituierten hydroxypiperidinen als antivirale mittel
US4985445A (en) 1988-02-12 1991-01-15 Meiji Seika Kaisha, Ltd. Cancer cell metastasis inhibitors and novel compounds
JPH0643306B2 (ja) * 1988-02-12 1994-06-08 明治製菓株式会社 癌細胞転移抑制剤
EP0350012A3 (en) * 1988-07-08 1990-09-05 Meiji Seika Kaisha Ltd. Antiviral composition
DE68925940T2 (de) * 1988-11-03 1996-10-24 Searle & Co Dideoxy-L-arabinitol Derivate als Antivirus-Verbindungen
US5256788A (en) 1989-02-13 1993-10-26 Nippon Shinyaku Co. Ltd. Moranoline derivatives and their production and the use of moranoline and its derivatives as a stabilizing agent for enzymes
JPH0675510B2 (ja) 1989-02-13 1994-09-28 日本新薬株式会社 モラノリン誘導体の製法
US5051401A (en) * 1989-04-07 1991-09-24 University Of South Alabama Inhibition of mineral deposition by phosphorylated and related polyanionic peptides
DE4009561A1 (de) 1990-03-24 1991-09-26 Bayer Ag Neue desoxynojirimycinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
WO1992000277A1 (fr) 1990-06-29 1992-01-09 Nippon Shinyaku Co., Ltd. Derive de piperidine
US5290948A (en) 1990-09-17 1994-03-01 Mcneilab, Inc. Process for producing polyhydroxylated piperidines and pyrrolidines and compounds thereof
DK0739205T3 (da) 1994-01-13 2000-05-01 Searle & Co Anvendelse af N-alkylderivater af 1,5-didesoxy-1,5-imino-D-glucitol til behandling af hepatitis-B-virusinfektioner
WO1995022975A1 (en) 1994-02-25 1995-08-31 G.D. Searle & Co. Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
MY122499A (en) * 1997-11-10 2006-04-29 Searle & Co Use of alkylated iminosugars to treat multidrug resistance
BR9907882A (pt) 1998-02-12 2000-10-17 Searle & Co Uso de compostos de 1,5-didesóxi-1,5-imino-d-glucitol n-substituìdos para o tratamento de infecções de vìrus de hepatite
GB0100889D0 (en) * 2001-01-12 2001-02-21 Oxford Glycosciences Uk Ltd Compounds
CN1422156A (zh) 2000-02-14 2003-06-04 法马西亚公司 N－取代的－1,5－二脱氧－1,5－亚氨基－d－葡萄糖醇化合物在治疗肝炎病毒感染中的用途
AU2003216664A1 (en) * 2002-03-13 2003-09-22 Aarnoud C. Van Der Spoel A non-hormonal approach to male contraception
JP4585851B2 (ja) * 2002-07-17 2010-11-24 アクテリオン ファーマシューティカルズ リミテッド グルコシルセラミドシンターゼの阻害剤としてのピペリジントリオール誘導体
ES2572148T3 (es) 2005-05-17 2016-05-30 Amicus Therapeutics Inc Un método para el tratamiento de la enfermedad de Pompe usando 1-desoxinojirimicina y derivados

Also Published As

Publication number Publication date
US20070275998A1 (en) 2007-11-29
HK1214261A1 (zh) 2016-07-22
CA2652958A1 (en) 2007-12-06
JP2009538336A (ja) 2009-11-05
EP2023927A2 (en) 2009-02-18
JP5241709B2 (ja) 2013-07-17
CN101489554A (zh) 2009-07-22
WO2007140184A2 (en) 2007-12-06
EP2023927B1 (en) 2015-02-25
WO2007140184A3 (en) 2008-11-27
CN104876855A (zh) 2015-09-02
CA2652958C (en) 2015-11-17
EP2023927A4 (en) 2013-04-10
US8975280B2 (en) 2015-03-10
JP2013129662A (ja) 2013-07-04

Similar Documents

Publication Publication Date Title
ES2537572T3 (es) Análogos de desoxinojirimicina y D-arabinitol y métodos de uso
EP1957086B1 (en) Nicotinoyl riboside compositions and methods of use
Asano et al. N-alkylated nitrogen-in-the-ring sugars: conformational basis of inhibition of glycosidases and HIV-1 replication
ES2292806T3 (es) Derivados azucar de hidromorfona, dihidromorfina y dihidroisomorfina, composiciones de los mismos y usos para tratar o prevenir el dolor.
DE69821520T2 (de) Verwendung von alkylierten iminozuckern zur behandlung von multipler medikamentenresistenz
WO2010029313A1 (en) Antiinfective compounds
López et al. Glycosidase inhibitors: versatile tools in glycobiology
CN115490681B (zh) 三嗪衍生物
Kato et al. Isolation and SAR studies of bicyclic iminosugars from Castanospermum australe as glycosidase inhibitors
ES2447740T3 (es) Derivado de piperidinilo como modulador de la actividad de los receptores de quimiocinas
EP3838901A1 (en) Compound for treatment of rabies and method for treatment of rabies
Front et al. N‐Alkyl‐, 1‐C‐Alkyl‐, and 5‐C‐Alkyl‐1, 5‐dideoxy‐1, 5‐imino‐(l)‐ribitols as Galactosidase Inhibitors
US20100113549A1 (en) Pyrrolidine compounds
US6020344A (en) Enzyme inhibitors and methods of use
Kooij et al. Glycosidase inhibition by novel guanidinium and urea iminosugar derivatives
Fröhlich et al. 1-Deoxy-d-galactonojirimycins with dansyl capped N-substituents as β-galactosidase inhibitors and potential probes for GM1 gangliosidosis affected cell lines
MXPA06000366A (es) Agonistas kappa.
Steiner et al. 1-Deoxygalactonojirimycin-lysine hybrids as potent D-galactosidase inhibitors
Lindbäck et al. Sugar hydrazide imides: a new family of glycosidase inhibitors
US20140296288A1 (en) Imino-sugar c-glycosides, preparation and use thereof
WO2008049950A1 (es) Nuevos sistemas polinitrogenados como agentes anti-vih
WO2017137895A1 (en) New dendrimeric pyrrolidines, their synthesis and medical use
WO2014017915A2 (en) Urea and guanidinium derivatives of iminosugars
Iftikhar et al. Modifications at the 6-O-position of 1-deoxynojirimycin: facile and efficient synthesis of 6-O-alkylated-N-octyl-1-deoxynojirimycin derivatives
Wang et al. Chemical synthesis and preliminary biological evaluation of C-6-O-methyl-1-deoxynojirimycin as a potent α-glucosidase inhibitor